346 related articles for article (PubMed ID: 16007211)
21. High prevalence of hepatitis B virus infection and inferior vena cava obstruction among patients with liver cirrhosis or hepatocellular carcinoma in Nepal.
Shrestha SM; Shrestha S; Shrestha A; Tsuda F; Endo K; Takahashi M; Okamoto H
J Gastroenterol Hepatol; 2007 Nov; 22(11):1921-8. PubMed ID: 17914971
[TBL] [Abstract][Full Text] [Related]
22. TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancer.
Hussain SP; Schwank J; Staib F; Wang XW; Harris CC
Oncogene; 2007 Apr; 26(15):2166-76. PubMed ID: 17401425
[TBL] [Abstract][Full Text] [Related]
23. Dominant role of hepatitis B virus and cofactor role of aflatoxin in hepatocarcinogenesis in Qidong, China.
Ming L; Thorgeirsson SS; Gail MH; Lu P; Harris CC; Wang N; Shao Y; Wu Z; Liu G; Wang X; Sun Z
Hepatology; 2002 Nov; 36(5):1214-20. PubMed ID: 12395332
[TBL] [Abstract][Full Text] [Related]
24. p53 mutations, chronic hepatitis B virus infection, and aflatoxin exposure in hepatocellular carcinoma in Taiwan.
Lunn RM; Zhang YJ; Wang LY; Chen CJ; Lee PH; Lee CS; Tsai WY; Santella RM
Cancer Res; 1997 Aug; 57(16):3471-7. PubMed ID: 9270015
[TBL] [Abstract][Full Text] [Related]
25. UDP-glucuronosyltransferase 1A7 genetic polymorphisms are associated with hepatocellular carcinoma risk and onset age.
Tseng CS; Tang KS; Lo HW; Ker CG; Teng HC; Huang CS
Am J Gastroenterol; 2005 Aug; 100(8):1758-63. PubMed ID: 16086712
[TBL] [Abstract][Full Text] [Related]
26. Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1.
Sun Z; Lu P; Gail MH; Pee D; Zhang Q; Ming L; Wang J; Wu Y; Liu G; Wu Y; Zhu Y
Hepatology; 1999 Aug; 30(2):379-83. PubMed ID: 10421643
[TBL] [Abstract][Full Text] [Related]
27. Nucleotide change of codon 38 in the X gene of hepatitis B virus genotype C is associated with an increased risk of hepatocellular carcinoma.
Muroyama R; Kato N; Yoshida H; Otsuka M; Moriyama M; Wang Y; Shao RX; Dharel N; Tanaka Y; Ohta M; Tateishi R; Shiina S; Tatsukawa M; Fukai K; Imazeki F; Yokosuka O; Shiratori Y; Omata M
J Hepatol; 2006 Dec; 45(6):805-12. PubMed ID: 17050029
[TBL] [Abstract][Full Text] [Related]
28. Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients.
Squadrito G; Pollicino T; Cacciola I; Caccamo G; Villari D; La Masa T; Restuccia T; Cucinotta E; Scisca C; Magazzu D; Raimondo G
Cancer; 2006 Mar; 106(6):1326-30. PubMed ID: 16453330
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance of aflatoxin, mutant P53 gene and sIL-2 receptor in liver cirrhosis and hepatocellular carcinoma.
El-Shanawani FM; Abdel-Hadi AA; Abu Zikri NB; Ismail A; El-Ansary M; El-Raai A
J Egypt Soc Parasitol; 2006 Apr; 36(1):221-39. PubMed ID: 16605112
[TBL] [Abstract][Full Text] [Related]
30. Hepatic aflatoxin B1-DNA adducts and TP53 mutations in patients with hepatocellular carcinoma despite low exposure to aflatoxin B1 in southern Japan.
Shirabe K; Toshima T; Taketomi A; Taguchi K; Yoshizumi T; Uchiyama H; Harimoto N; Kajiyama K; Egashira A; Maehara Y
Liver Int; 2011 Oct; 31(9):1366-72. PubMed ID: 21745313
[TBL] [Abstract][Full Text] [Related]
31. Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma.
Chen CC; Yang SY; Liu CJ; Lin CL; Liaw YF; Lin SM; Lee SD; Chen PJ; Chen CJ; Yu MW
Int J Epidemiol; 2005 Dec; 34(6):1310-8. PubMed ID: 16172101
[TBL] [Abstract][Full Text] [Related]
32. Combined mutations in pre-s/surface and core promoter/precore regions of hepatitis B virus increase the risk of hepatocellular carcinoma: a case-control study.
Chen CH; Changchien CS; Lee CM; Hung CH; Hu TH; Wang JH; Wang JC; Lu SN
J Infect Dis; 2008 Dec; 198(11):1634-42. PubMed ID: 18939932
[TBL] [Abstract][Full Text] [Related]
33. [p53 gene mutation in hepatocellular carcinoma].
Jiang W; Lu Q; Pan G
Zhonghua Wai Ke Za Zhi; 1998 Sep; 36(9):531-2. PubMed ID: 11825456
[TBL] [Abstract][Full Text] [Related]
34. Ser-249TP53 mutation in tumour and plasma DNA of hepatocellular carcinoma patients from a high incidence area in the Gambia, West Africa.
Szymańska K; Lesi OA; Kirk GD; Sam O; Taniere P; Scoazec JY; Mendy M; Friesen MD; Whittle H; Montesano R; Hainaut P
Int J Cancer; 2004 Jun; 110(3):374-9. PubMed ID: 15095302
[TBL] [Abstract][Full Text] [Related]
35. Role of hepatitis B virus precore/core promoter mutations and serum viral load on noncirrhotic hepatocellular carcinoma: a case-control study.
Liu CJ; Chen BF; Chen PJ; Lai MY; Huang WL; Kao JH; Chen DS
J Infect Dis; 2006 Sep; 194(5):594-9. PubMed ID: 16897657
[TBL] [Abstract][Full Text] [Related]
36. Risk for hepatocellular carcinoma with respect to hepatitis B virus genotypes B/C, specific mutations of enhancer II/core promoter/precore regions and HBV DNA levels.
Yuen MF; Tanaka Y; Shinkai N; Poon RT; But DY; Fong DY; Fung J; Wong DK; Yuen JC; Mizokami M; Lai CL
Gut; 2008 Jan; 57(1):98-102. PubMed ID: 17483190
[TBL] [Abstract][Full Text] [Related]
37. A p53 genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriers.
Yu MW; Yang SY; Chiu YH; Chiang YC; Liaw YF; Chen CJ
Hepatology; 1999 Mar; 29(3):697-702. PubMed ID: 10051470
[TBL] [Abstract][Full Text] [Related]
38. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
[TBL] [Abstract][Full Text] [Related]
39. [A 1:1 matched case-control study on the interaction between HBV, HCV infection and DNA repair gene XPC Ala499Val, Lys939Gln for primary hepatocellular carcinoma].
Cai XL; Gao YH; Yu ZW; Wu ZQ; Zhou WP; Yang Y; Xu Y; Song SF; Chen SD
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Sep; 30(9):942-5. PubMed ID: 20193233
[TBL] [Abstract][Full Text] [Related]
40. Infrequent mutation of p53 gene in hepatitis B virus positive primary hepatocellular carcinomas.
Hosono S; Chou MJ; Lee CS; Shih C
Oncogene; 1993 Feb; 8(2):491-6. PubMed ID: 8093978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
